Cardiorentis

Developer of natriuretic peptides for the treatment of cardiovascular diseases

placeZug, Canton Of Zug, Switzerland calendar_todayFounded 2010 groups9 employees language cardiorentis.com

Innovation

2 patent families (1 granted) — focus: Human necessities; filing pace dormant. Cited 73 times.

YearFilings
20142
20151
20161
20171

Investor mix

2 investors on record; lead investors include HealthCare Royalty Partners.

Investor typeCountShare
Venture capital150%
Private equity150%
Coming soon